Suvretta Capital Management is a fund manager in New York with $7.10 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
453704500
SEC advisor number
801-79962
FINRA CRD number
165153
AUM ?
$5.16 bn
(as of 14 Jun 23)
Accounts
15
(as of 14 Jun 23)
Employees
32
(18 investment advisory or research)
Address
Suvretta Capital Management
540 MADISON AVENUE
7TH FLOOR
NEW YORK
NY 10022
540 MADISON AVENUE
7TH FLOOR
NEW YORK
NY 10022
Phone
2127025204
Brochures
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Suvretta Capital Management, LLC | $7.10 bn | |
Averill Master Fund, LTD. | $1.97 bn | Hedge Fund |
Averill Fund, LTD. | ||
Averill Partners, LP | ||
Averill Opportunities Offshore Fund I, LP | $15.05 mm | Venture Capital Fund |
Averill Opportunities Fund I, LLC | ||
Suvretta Long Master Fund, LTD. | $52.36 mm | Hedge Fund |
Suvretta Long Partners, LP | ||
Suvretta Long Fund, LTD. | ||
Suvretta Master Fund, LTD. | $5.02 bn | Hedge Fund |
Suvretta Offshore Fund, LTD. | ||
Suvretta Partners, LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G
Contineum Therapeutics, Inc.
15 Apr 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G/A
Spyre Therapeutics, Inc.
13 Feb 24
SC 13G/A
PROKIDNEY CORP.
13 Feb 24
SC 13G/A
Mereo BioPharma Group plc
13 Feb 24
SC 13G/A
Kura Oncology, Inc.
13 Feb 24
SC 13G/A
KalVista Pharmaceuticals, Inc.
13 Feb 24
SC 13G/A
Benitec Biopharma Inc.
13 Feb 24
SC 13G/A
Biohaven Ltd.
13 Feb 24
SC 13G/A
Arcutis Biotherapeutics, Inc.
13 Feb 24